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Abstract
Objective: The aim of this prospective, unblinded, randomized study was to provide performance data of the
prototype of new electromyography-based neuromuscular monitor, the NEAT device (Acacia Designs BV,
Amsterdam, the Netherlands) and assess the subjective discomfort associated with neurostimulation in unmedicated
healthy volunteers.
Methods: The study enrolled ten male and ten female volunteers. Based on a priori randomization the ulnar
nerve of the left or right arms was stimulated in 1 Hz single twitch and train-of-four modes. Stimulating current
intensity was increased from 10 mA to 60 mA in 10 mA steps. Electromyography recordings were performed at the
abductor digiti minimi and adductor pollicis muscles via surface electrodes. The volunteers were asked to rate the
discomfort in association with neurostimulation on a 0-10 visual analogue scale.
Results: The overall train-of-four ratio was 1.02 (0.98-1.06) {median and (interquartile range)}. The abductor digiti
minimi muscle required lower stimulating current intensity to evoke maximal stimulation, than the adductor pollicis
(30 vs. 50 mA, p<0.001). The overall intracurrent variability of compound muscle action potential amplitudes was
0.42 (0.21-0.87) mV, that was unaffected by the type of muscle or the stimulating current intensity. Women reported
moderately higher visual analogue scale scores than men. The largest recorded difference was 5 (3.75-6) vs. 3
(3-4), p<0.05.
Conclusion: The Acacia Designs BV NEAT monitoring device was suitable to deliver neurostimulation, record
and analyze the elicited muscle action potentials. The precision of stimulations was acceptable. The volunteers
reported the discomfort in association with neurostimulation as tolerable.
Registered at the Hungarian Office for Health Authorization and Administrative Procedures (December 30th,
2014). Identifier: 028605-010/2014/OTIG. Registered at clinicaltrials.gov (December 15th, 2015). Identifier:
NCT02630576.
Keywords: Neuromuscular monitoring; Electromyography; Visual
analogue scoring scale; Abductor digiti minimi muscle; Adductor
pollicis muscle
Abbreviations: AMG: Acceleromyography; ASA: American Society
of Anesthesiology; CMAP: Compound Muscle Action Potential; ECG:
Electrocardiography; EMG: Electromyography; IMax: Current Intensity
that Elicited the Highest Compound Muscle Action Potential; ITh:
Threshold Current Intensity; ITh-Clinical: Clinical Threshold Current
Intensity; ITh-EMG: Electromyographical Threshold Current Intensity;
IQR: Interquartile Range; mADM: Abductor Digiti Minimi Muscle;
mAP: Adductor Pollicis Muscle; μC: Microcoulombs; mA:
Milliampere; msec: Millisecond; mV: Millivolt; MMG:
Mechanomyography; NM: Neuromuscular; PACU Post-Anesthesia
Care Unit; PTC: Post-Tetanic Count; SD: Secure Digital; SD: Standard
Deviation; ST: Single Twitch; TOF: Train-of-Four; TOFC: Train-of-
Four Count; VAS: Visual Analogue Scale
Introduction
Objective neuromuscular (NM) monitors help optimize the timing
and dosing of neuromuscular blocking agents, the timing of safe
tracheal extubation at the end of operations, and thus decrease the
incidence of residual paralysis and its postoperative consequences
[1-4]. Over the last few years, a strong educational effort has been
observed, which urged the extended use of NM monitors to improve
patient safety and outcomes [2,3,5-8]. In 2009 Kopman proposed that
objective neuromuscular monitors be available in any modern
anesthetizing location when neuromuscular blocking drugs are
administered [9]. In 2016, the Association of Anaesthetists of Great
Britain and Ireland prescribed the use of peripheral nerve stimulators
whenever NM blocking agent is administered and recommended the
use of quantitative monitors [10].
Despite its known limitations, the acceleromyography (AMG)
based, portable TOF-Watch series was one of the most frequently used
NM monitor in clinical practice and research. Most recommendations
on safe management of NM blockade were based on AMG
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investigations [1,11]. However, in 2016 the TOF-Watch NM monitors
were withdrawn from manufacture. Thus, within a short time, there
will be a significant lack of options in the spectrum of stand-alone NM
monitors that cannot be overcome by modular original equipment
manufacturer NM monitors that are integrated into anesthesia
workstations. One reason is that not all anesthesia workstations are
equipped with NM modules. In addition, the integrated NM monitors
usually are not transported with the patient from the operating room
to the postoperative care unit (PACU), which increases the need for
additional NM monitors in the PACU. Therefore, there is an increasing
need for easy-to-use, reliable, portable NM monitors.
Before the introduction of acceleromyography in the 1980s,
mechanomyography (MMG) and electromyography (EMG) were the
means to measure neuromuscular function. Although MMG was
considered the “gold standard” neuromuscular monitor, it was too
bulky for routine use and cumbersome for clinical purposes [2,7],
EMG proved to be an excellent alternative. Electromyography
measures directly the electrical events of neuromuscular signal
transmission, the compound muscle action potentials (CMAP). For
this reason, EMG is less susceptible to interference from presynaptic or
postsynaptic events, and is likely a better indicator of pure
neuromuscular function [2]. Therefore, it is probably the most
physiologic and precise method of measuring the synaptic
transmission, and thus the degree of NM relaxation [3]. Other
practical advantages of EMG over MMG and AMG are that EMG does
not require the complete immobilization of the hand, the fixation of
the arm in the supine position or the use of a muscle preload.
Additionally, the staircase phenomenon does not affect EMG
measurements [12], unlike MMG and AMG; therefore, the calibration
of the device to determine the supramaximal stimulating current
intensity is simpler and shorter. Yet, currently there is no freestanding,
hand-held EMG-based NM monitor available in the market. To our
knowledge, there are only a couple of anesthesia workstation
integrated NM transmission modules that use electromyography or
kinemyography (GE Healthcare, Waukesha, WI, USA) [3], or
acceleromyography (IntelliVue NMT, Philips, Amsterdam, the
Netherlands; Infinity Trident NMT SmartPod, Dräger, Lübeck,
Germany) [3].
The Acacia Designs’ prototype monitor (NEAT device, Amsterdam,
the Netherlands) is a dedicated electromyography-based NM monitor
intended to deliver, record, and analyse CMAPs. The NEAT device is
the first prototype of the TetraGraphTM neuromuscular monitor
(Senzime BV, Uppsala, Sweden). The prototype was designed to
conduct preclinical investigations. It is battery-powered, uses simple
electrocardiography (ECG) electrodes both for stimulation and
recording, and registers data on an integrated secure digital (SD) card.
The stimulating parameters of the prototype match the parameters of
the TetraGraphTM. The aim of the current investigation was to test the
prototype that uses the design and electronics intended for the final
product, gain performance data and assess the discomfort evoked by
neurostimulation in unmedicated, healthy volunteers.
Materials and Methods
This prospective, unblinded, randomized, single-center study was
approved by the Hungarian Office for Health Authorization and
Administrative Procedures (028605-010/2014/OTIG) and registered at
clinicaltrials.gov (NCT02630576). Data presentation is in accordance
with CONSORT 2010 guidelines.
Volunteers
The study population consisted of normal, healthy volunteers of age
18 years and older, American Society of Anesthesiology (ASA) physical
status I. Ten male and ten female volunteers were enrolled in the study
(Figure 1). All subjects were required to provide written informed
consent prior to inclusion in the study. Exclusion criteria were presence
of an underlying neuromuscular disease, use of medications known to
interfere with neuromuscular transmission (e.g., antiepileptics,
anticholinesterases and magnesium sulphate), presence of renal or
hepatic disease, or presence of open sores at the skin sites needed for
electrode application.
Figure 1: CONSORT study flowchart.
Device specifications
The NEAT device is the first prototype of a new electromyography-
based, battery-powered, portable neuromuscular monitor, whose
software was specially developed for research and clinical purposes. It
can stimulate the peripheral nerves using parameters and settings
currently in use by many peripheral nerve stimulators, and record the
evoked muscle response (CMAP). Data is saved onto an SD-card for
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subsequent review and analysis. All possible stimulation settings that
will be available on the final device were incorporated into this
prototype. These available stimulation settings were: variable
stimulation current (10-60 mA, in 10 mA steps); stimulation protocol
{train-of-four (TOF), 1 Hz single twitch (ST), train-of-four count
(TOFC) and post-tetanic count (PTC)}; time interval between
sequential protocols (every 20 s, 1 min, 5 min, 15 min, 60 min except
for the PTC protocol, for which the interval is 3 min minimum
between successive stimulations); and stimulus pulse width (0.2 or 0.3
msec). The prototype was fully battery powered (Varta EZPack XL Li-
Polymer rechargeable battery, 3.7 V, 2260 mAh, 8.4 Wh, Utrecht, the
Netherlands). The NEAT device was used with a double-shielded
monitor-to-patient cable and commercially available surface ECG
electrodes (3M Red Dot, St. Paul, MN, USA).
Subject preparation and neurostimulation
Neuromuscular testing was performed at two separate stimulation/
recording sites: ulnar nerve stimulation and abductor digiti minimi
muscle (mADM) recording; as well as ulnar nerve stimulation and
adductor pollicis muscle (mAP) recording (Figure 2). The side of
testing (right or left hand) was determined a priori via envelope
randomization, to ensure that 10 volunteers (5 male and 5 female) each
were tested on the right and 10 on the left hands.
Figure 2: Stimulating and recording electrode placement.
Stimulating electrodes are placed along the ulnar nerve. The
positive electrode is placed proximally, the negative electrode
distally. The active recording electrodes are placed on the bellies of
the abductor digiti minimi (hypothenar eminence) and adductor
pollicis (thenar eminence) muscles. The reference electrodes are
placed above the first interphalangeal joint of the little finger and
the thumb (tendon insertion sites).
The stimulating ECG electrodes were placed on the lightly abraded,
alcohol-cleansed skin over the ulnar nerve of the randomized volar
forearm near the wrist. The negative (distal) electrode was placed on
the ulnar side of the volar forearm, 2 cm-3 cm proximal to the flexor
crease. The positive electrode was placed with its center 3 cm
proximally to the negative electrode. The recording electrodes were
placed (after proper skin cleaning with alcohol and abrasion) on the
thenar and the hypothenar eminence (on the muscle belly of the mAP
and mADM, respectively) and reference electrodes on the first
interphalangeal joints (muscle insertion) of the thumb and the fifth
finger, respectively (Figure 2).
The stimulation protocols (ST and TOF) were identical for the two
muscles. The stimulating parameters of ST stimulation were 1 Hz
frequency, 0.2 msec pulse width and 10-60 mA current intensity that
was increased in 10 mA steps. The stimulating parameters of TOF
stimulations were 0.2 msec pulse width, 20 sec interval time between
TOF sequences, and 10-60 mA current intensity levels, increased in 10
mA steps. All ST and TOF stimulations were repeated three times at
each current intensity level.
All measurements were saved to the built-in SD card of the
device for off-line analysis
The lowest current intensity of any stimulation mode that elicited a
repeatable visible muscle contraction (twitch) in the fingers was
considered the clinical threshold current intensity (ITh-clinical) and was
recorded on the data sheet. This was compared to the lowest current
intensity that could elicit a measurable CMAP (ITh-EMG). The current
intensities that elicited the highest CMAP amplitudes (IMax) were
noted.
The volunteers were asked to rate the discomfort of
neurostimulation at every current intensity of each stimulation mode
on a 0-10 visual analogue scoring (VAS) scale. Zero represented “no
discomfort” and 10 represented “worst pain ever experienced” elicited
by the stimulation. Whenever the VAS score exceeded 6 points, the
volunteers were asked if they gave their consent to continue the
measurement. No volunteer was asked to undergo neurostimulation if
he/she felt it would be intolerable.
Study objectives and endpoints
The primary objective of the study was to provide performance data
of the Acacia Designs BV NEAT prototype monitoring device in
volunteers and assess the subjective discomfort associated with
neurostimulation.
Primary endpoint of the study:
- Assessment of the ability of the prototype to deliver
neurostimulation, and assessment of the ability to acquire muscle
action potentials, analyze and record these evoked responses on the
SD-card.
Secondary endpoints included:
- Confirmation that the prototype can independently stimulate and
record repetitive patterns of neurostimulation, including 1 Hz ST and
TOF stimulation protocols;
- Verification of the delivery of neurostimulation at varying current
intensities, from the lowest current intensity that produces an evoked
response (threshold current, ITh-EMG) to the current intensity above
which the evoked response no longer increases (maximal current,
IMax), at increasing current levels separated by steps of 10 mA;
- Examination of the intracurrent variability of CMAP amplitudes
evoked by 10-60 mA ST stimulation (difference of highest and lowest
CMAP amplitudes at the given intensity). Determine any difference in
recording performance between the two hand muscles, two sexes, and
dominant vs. non-dominant hand;
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- Validation of the consistency of TOF stimulations and their
deviation from the ideal 1.0 value in unmedicated volunteers.
Determine any difference in recording performance between the two
hand muscles (mAP and mADM), two sexes, and dominant or non-
dominant hand;
- Establishment of discomfort, if any, associated with nerve
stimulation in the awake, unmedicated volunteers. A visual analogue
scoring scale, anchored with 0 (representing no distress) and 10
(representing the worst pain ever experienced) was used to rate the
level of discomfort;
- Assessment of skin reactions to the stimulation or recording
electrodes, if any.
Data analysis
All measurements were saved on the internal SD card of the device
for post hoc analysis. MATLAB TetraAnalyzerViewer2014a64 software
(MathWorks, Natick, MA, USA) was used to measure CMAPs and
TOF ratios.
When the parametric assumptions of normality and equal variance
were met, paired T-test was used to compare data pairs from the same
volunteer and Student’s T-test and one-way ANOVA to compare study
groups. When the above assumptions were not met, paired Signed
Rank test, Mann-Whitney U-test and One-way ANOVA on Ranks
were used. For normally distributed variables, mean ± standard
deviation (SD) and for non-normally distributed variables, median and
the interquartile range (IQR) are presented. The predetermined level of
significance was p<0.05. Sigma-Plot for Windows Version 11.0 (Systat
Software Inc., San Jose, California, USA) was used for calculations.
Results
Demographic data
Demographic data of the volunteers are summarized in Table 1.
There was no statistical difference in age (p=0.592), body mass index
(p=0.231) and handedness (p=1.0) among the four groups. All
volunteers were right-handed, therefore the terms dominant and non-
dominant side refer to all volunteers. The female and male groups had
similar body weight (p=0.145), height (p=0.684) and wrist
circumference (p=0.247).
Male
Left hand
Male
Right hand
Female
Left hand
Female
Right hand p
Age (years)
median (IQR) 23 (22.75-30.25) 24 (23.75-33) 24 (22.75-44.25) 23 (21.75-28) 0.59
BMI (kg/m2)
mean (SD) 25.04 (3.43) 22.72 (3.19) 26.48 (6.89) 21.05 (1.95) 0.23
Body weight (kg)
mean (SD) 79.6 (9.81)* 71.6 (12.92)* 73.8 (16.86) † 60.4 (7.8) †
*0.30
† 0.15
Height (cm)
mean (SD) 178.4 (4.39)* 177.2 (8.2)* 167.6 (4.83) † 169.2 (6.98) †
*0.78
† 0.68
Wrist circumference (mm)
mean (SD) 176.2 (6.18)* 171.2 (8.9)* 164.2 (12.38) † 156.2 (6.54) †
*0.33
† 0.25
Left:Right-handed 0:5 0:5 0:5 0:5 1:0
Table 1: Demographic data of the volunteers. Statistical comparison of age and BMI was performed for all study groups. Body weight, height and
wrist circumference were statistically compared between the same sex groups. * represents the p value for the male groups, † represents the p
value for the female volunteers.
Threshold stimulating current intensity
The threshold current intensity that could elicit visible muscle
twitches (ITh-clinical) and recordable CMAPs (ITh-EMG) was found to be
20 (20-30) mA {median (IQR)}. The clinical examination (ITh-clinical)
and monitor (ITh-EMG) recordings were congruent (p=0.854) in 64 out
of 80 stimulation protocols (80%). Women needed significantly lower
current intensity than men to elicit recordable CMAPs {20 (20-20) vs.
30 (20-30) mA, p=0.002}. The abductor digiti minimi muscle had
lower ITh-EMG than the adductor pollicis {23.75 ± 7.0 vs. 25.5 ± 6.78
mA (mean ± SD), p=0.039)}. There was a moderate correlation
between wrist circumference and ITh-EMG (Pearson’s r=0.51, p=0.0217)
and between BMI and ITh-EMG (Pearson’s r=0.505, p=0.023).
CMAP amplitude tendencies at increasing intensity ST
stimulation
Increasing current intensities resulted in the increase of elicited
CMAP amplitudes (Figure 3). The current intensity that induced the
highest CMAPs (IMax) was significantly different between the two
muscles. The mADM needed lower current intensity than mAP to
reach maximal stimulation {30 (20-40) mA vs. 50 (50-60) mA,
respectively, p<0.001}. During maximal stimulation, the highest
elicited CMAP amplitudes were moderately lower in the mADM
(10.40 ± 1.9 mV) than in the mAP (12.84 ± 5.1 mV), p=0.031.
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Figure 3: Compound muscle action potentials evoked by increasing intensity stimulation in the two muscles. mADM=abductor digiti minimi
muscle, mAP=adductor pollicis muscle. The boxplots represent median with interquartile ranges, the error bars represent 10th and 90th
percentiles and the dots represent minimum and maximum values. Boxplots were created in Sigma-Plot for Windows Version 11.0 (Systat
Software Inc., San Jose, California, USA).
Female volunteers had higher CMAP amplitudes than men at the
same stimulating current intensity, especially in the dominant mAP.
Also, the female volunteers required lower stimulating current
intensity to elicit maximal CMAP amplitudes than men {40 (20-50) vs.
45 (30-60) mA, respectively, p=0.042}.
Consistency of CMAP amplitudes (intracurrent differences)
in ST protocol at increasing stimulation current
The consistency of CMAP amplitudes was examined in 240 ST
stimulation protocols (20 volunteers × 2 muscles × 6 current
intensities). Of these, 59 stimulation protocols were excluded from the
analysis because the current was under the threshold to evoke
measurable CMAP. Another 4 protocols were missed because two
female volunteers wished to discontinue the testing at higher (50-60
mA) current intensity. Altogether, CMAP amplitude consistency was
examined in 177 cases (73.75%). The overall intracurrent difference,
when the results of all stimulating intensities were pooled, was 0.42
(0.21-0.87) mV. In 145/177 (81.92%) of cases, the intracurrent
difference was <1.0 mV (Figure 4). There was no statistical difference
in the consistency of CMAP amplitudes between sexes {men: 0.37
(0.18-0.84) mV vs. women: 0.47 (0.25-0.87 mV, p=0.285} or between
the two muscles {mADM: 0.42 (0.24-0.90) vs. mAP: 0.44 (0.19-0.87)
mV, respectively, p=0.511}. The stimulating current intensity (20, 30,
40, 50, 60 mA) did not influence the level of intracurrent CMAP
amplitude variability during ST stimulation {0.36 (0.24-1.13), 0.28
(0.20-1.01), 0.33 (0.17-0.61), 0.67 (0.21-0.89), 0.30 (0.15-0.83),
respectively, p=0.688}, if it was high enough to evoke reproducible
CMAPs.
Figure 4: Overall intracurrent compound muscle action potential
(CMAP) amplitude variability during single twitch (ST)
stimulation. The histogram was created in Sigma-Plot for Windows
Version 11.0 (Systat Software Inc., San Jose, California, USA).
Consistency of TOF measurements
Seven hundred-twenty TOF measurements were performed in the
study (20 volunteers × 2 muscles × 6 current intensities × 3
stimulations at each current intensity). TOF analysis could be
performed in 532 (74%) cases, those in which the stimulating current
intensity was sufficient to elicit CMAPs and produce TOF ratios. Two
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female volunteers declined TOF stimulation at 50 mA and 60 mA. In 4
cases, false detection was experienced, as only a TOF count was
determined instead of TOF ratio. The overall consistency of elicited
TOF ratios was 1.02 (0.98-1.06). In 445/532 (83.64%) of cases, the TOF
ratios were in the range of 0.9-1.1 (Figure 5). The TOF ratios were
closer to the expected 1.0 in men than in women {1.01 (0.97-1.06) vs.
1.02 (0.99-1.05), respectively, p=0.029} and in mADM than in mAP
{1.01 (0.98-1.05) vs. 1.02 (0.99-1.06), respectively, p=0.031}. The
stimulating current intensity (20, 30, 40, 50, 60 mA) did not influence
the precision of TOF ratio measurement {1.03 (0.99-1.06), 1.02
(0.99-1.07), 1.01 (0.97-1.05), 1.01 (0.98-1.06), 1.02 (0.99-1.05),
respectively, p=0.256}.
Figure 5: Overall train-of-four ratio variability. The histogram was
created in Sigma-Plot for Windows Version 11.0 (Systat Software
Inc., San Jose, California, USA).
VAS scores
Figure 6 shows the VAS scores associated with ST and TOF
stimulation protocols at increasing current intensities. The data
obtained from the two arms and two muscles of both sex groups were
pooled because they did not show statistical difference. The level of
discomfort and the corresponding VAS scores increased as a function
of increasing stimulating current intensity for both ST and TOF
stimulation. Women had higher VAS scores than men at the same
current intensities. The largest recorded difference in VAS scores was 5
(3.75-6) vs. 3 (3-4), respectively, at 60 mA TOF stimulation, (p=0.01).
Two female volunteers refused ST and TOF stimulation at 50 and 60
mA, due to discomfort at 40 mA. The other eighteen volunteers
tolerated all stimulation current intensities well. IMax stimulating
current intensity was associated with a median VAS score of 3 (2-5) in
the pooled cohort.
Skin irritation
Two volunteers presented mild, painless hyperemia at the
stimulation site after removing the ECG electrodes. The hyperemia
disappeared in a few minutes and no further irritation or adverse
events were reported.
Figure 6: Visual analogue scale scores as a function of increasing
intensity single twitch and train-of-four stimulation. Bars represent
median values; error bars represent maximal values. Data of left-
and right-hand groups of volunteers of the same sex and the two
muscles are pooled. M-male groups, F-female groups. The boxplot
was created in Sigma-Plot for Windows Version 11.0 (Systat
Software Inc., San Jose, California, USA).
Discussion
The aim of this preclinical investigation was to obtain performance
data on the prototype of a new EMG-based neuromuscular monitor.
The Acacia Designs BV NEAT monitoring device was able to deliver
neurostimulation, record and analyse the elicited muscle action
potentials. The maximal CMAP amplitudes of mADM due to ulnar
nerve stimulation corresponded to previously reported database
normal values [13].
Kopman and Paulus have shown that the current required to
produce a detectable muscle twitch via cutaneous electrodes is 5-25
mA, while the current required for supramaximal stimulation is 30-60
mA [14-16]. Our results are comparable with these previous reports.
However, current intensity (in mA) is not the sole factor that
determines the strength (charge) of neurostimulation. The actual
charge (in microcoulombs, μC) that is delivered to the stimulated
nerve is the product of the current intensity (in mA) and the pulse
width (in msec). In general, charges of 12-15 μC are required for a
maximal muscle response, although some muscles have even higher
requirements [2,17]. In this equation, the more influential factor is
pulse duration. Decreasing the pulse width from 0.2 msec to 0.1 msec
(a 50% reduction) would require a doubling of the stimulating current
intensity (from 60 mA to 120 mA) in order to maintain the stimulation
charge constant. However, using such high current intensities could be
extremely painful to the patients. In this study, 6 volunteers rated the
discomfort associated with 60 mA stimulations more than 6 points on
the 0-10 VAS scale. However, the stimulating current intensity
necessary for supramaximal stimulation is between 0-70 mA with a
pulse duration of 0.2-0.3 msec [1,3]. These parameters can ensure the
delivery of supramaximal stimulation without causing direct muscle
stimulation that might be elicited by pulse durations in excess of 3-400
msec [2]. The NEAT device meets these requirements as it can deliver
ST and TOF stimulation at currents of 10-60 mA in 10 mA increments
with a 0.2-0.3 msec pulse width.
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We aimed to obtain performance data in various subjects; therefore,
the demographic characteristics of the volunteers were not
standardized. The male and female volunteers showed a difference
regarding threshold current (ITh), but the sex of volunteers did not
influence the reproducibility (consistency) of ST stimulations. In this
cohort, women required lower stimulating currents to elicit recordable
CMAPs, and similar intensity stimulation produced higher muscle
responses (Figure 3). It is presumed that female volunteers had lower
skin impedance. This could have resulted in higher total stimulus
charges delivered to the ulnar nerve and higher muscle action
potentials. This is consistent with the slightly higher VAS scores
reported by female volunteers compared with their male counterparts.
However, there was only moderate correlation between BMI or wrist
circumference and the threshold current to evoke CMAP as it was
previously described by Kopman [14].
Phillips et al. previously studied the evoked electromyographic
responses to supramaximal TOF stimulation at the mAP and mADM
during recovery from non-depolarizing neuromuscular blockade [18].
They found that the mADM was more resistant to NM blockade and
recovered faster than mAP. They also concluded that EMG recordings
from mADM were more precise. The repeatability coefficient was
lower for mADM than for mAP (4.4% vs. 5.9%, respectively) [18]. In
this study, the mADM required 20 mA lower stimulating current
intensity to reach maximal stimulation (IMax). This resulted in a 1.86-
point lower VAS scores on the average, hence less discomfort at
clinically required maximal stimulation. Additionally, the TOF ratios
recorded from mADM were closer to the expected value of 1.0. This
greater consistency of evoked responses and lower stimulating energy
(charge) requirement may make the mADM preferable for monitoring
awake patients in the postoperative setting without needing to employ
submaximal currents, but this needs further investigation.
Helbo-Hansen et al. studied the repeatability of TOF ratios at
varying stimulating currents in anesthetized patients [19]. They found
that the accuracy of TOF monitoring was poor at low stimulating
currents close to ITh. Good repeatability was achieved only above 45
mA stimulating current intensity or ITh+25 mA.
There is a controversy in the literature about the ideal stimulating
current for awake patients. Involuntary movement in response to a
painful stimulus (withdrawal, contractions) might alter measurements.
At the same time, low currents might not deliver equal charges to each
stimulus in the TOF sequence. It was previously speculated that
submaximal (20-30 mA) stimulation should be used in an awake
patient as the best compromise of patient discomfort and repeatability
[16,20]. However, another study revealed only moderate agreement
between two AMG measurements with 30 mA in the postoperative
care unit [21]. In general, our volunteers found the discomfort
associated with increasing current intensity acceptable. Our VAS scores
were comparable to those in previous reports [16,17,22]. In this setting,
the stimulating current did not influence the repeatability of TOF
measurements; however the study was underpowered for this purpose.
In conclusion, the performance of the electromyography based
Acacia Designs BV NEAT device, the prototype of future
TetraGraphTM neuromuscular monitor, was acceptable. The present
electronics and design would be compatible with the surgical
environment. The interface of the device is user-friendly and intuitive.
Following further development, the future TetraGraphTM monitor
may prove to be an easy to use, reliable and portable NM monitor that
fits well in the surgical environment and anesthesia practice.
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